[1]
Mahtab, M.A., Tabassum, S., Nesa, A., Jahan, M., Khan, M.S.I. and Akbar, S.M.F. 2019. A new therapeutic option for chronic hepatitis B: Reduced dose and shorter duration of a combination therapy with pegylated interferon and entecavir. Bangladesh Medical Research Council Bulletin. 45, 3 (Dec. 2019), 143–148. DOI:https://doi.org/10.3329/bmrcb.v45i3.44643.